Detalhe da pesquisa
1.
A basophil-neuronal axis promotes itch.
Cell
; 184(2): 422-440.e17, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450207
2.
Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.
J Allergy Clin Immunol
; 151(3): 756-766, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084766
3.
Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study.
Br J Dermatol
; 189(6): 685-694, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562034
4.
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Clin Exp Allergy
; 51(7): 915-931, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037993
5.
Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS.
J Am Acad Dermatol
; 82(6): 1328-1336, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135208
6.
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
J Am Acad Dermatol
; 82(2): 377-388, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31374300
7.
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
J Allergy Clin Immunol
; 143(1): 155-172, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194992
8.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
N Engl J Med
; 375(24): 2335-2348, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27690741
9.
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
J Drugs Dermatol
; 18(8): 804-813, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424712
10.
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
Lancet
; 387(10013): 40-52, 2016 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454361
11.
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
N Engl J Med
; 371(2): 130-9, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006719
12.
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
J Am Acad Dermatol
; 74(3): 491-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777100
13.
Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
J Am Acad Dermatol
; 75(3): 506-515, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27268421
14.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
N Engl J Med
; 376(11): 1090-1, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296614
15.
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.
Dermatol Ther (Heidelb)
; 14(2): 533-543, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326699
16.
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
Adv Ther
; 40(12): 5366-5382, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801232
17.
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year.
Dermatol Ther (Heidelb)
; 12(1): 9-13, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994968
18.
Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
J Dermatol
; 49(9): 903-911, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715964
19.
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis.
Clin Transl Sci
; 15(10): 2342-2354, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986664
20.
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
J Dermatolog Treat
; 33(5): 2565-2570, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255779